Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe S Flaxman, S Mishra, A Gandy, HJT Unwin, TA Mellan, H Coupland, ... Nature 584 (7820), 257-261, 2020 | 4075* | 2020 |
Genomics and epidemiology of the P. 1 SARS-CoV-2 lineage in Manaus, Brazil NR Faria, TA Mellan, C Whittaker, IM Claro, DS Candido, S Mishra, ... Science 372 (6544), 815-821, 2021 | 1583 | 2021 |
SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion P Mlcochova, SA Kemp, MS Dhar, G Papa, B Meng, IATM Ferreira, R Datir, ... Nature 599 (7883), 114-119, 2021 | 1225 | 2021 |
Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study AB Hogan, BL Jewell, E Sherrard-Smith, JF Vesga, OJ Watson, ... The Lancet global health 8 (9), e1132-e1141, 2020 | 834 | 2020 |
Evolution and epidemic spread of SARS-CoV-2 in Brazil DS Candido, IM Claro, JG De Jesus, WM Souza, FRR Moreira, ... Science 369 (6508), 1255-1260, 2020 | 666 | 2020 |
Reduction in mobility and COVID-19 transmission P Nouvellet, S Bhatia, A Cori, KEC Ainslie, M Baguelin, S Bhatt, ... Nature communications 12 (1), 1-9, 2021 | 572 | 2021 |
Age groups that sustain resurging COVID-19 epidemics in the United States M Monod, A Blenkinsop, X Xi, D Hebert, S Bershan, S Tietze, M Baguelin, ... Science 371 (6536), eabe8372, 2021 | 332 | 2021 |
Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India MS Dhar, R Marwal, R Vs, K Ponnusamy, B Jolly, RC Bhoyar, V Sardana, ... Science 374 (6570), 995-999, 2021 | 316 | 2021 |
Imperial College COVID-19 Response Team S Flaxman, S Mishra, A Gandy, HJT Unwin, TA Mellan, H Coupland, ... Estimating the effects of non-pharmaceutical interventions on COVID-19 in …, 2020 | 301 | 2020 |
Understanding the effectiveness of government interventions against the resurgence of COVID-19 in Europe M Sharma, S Mindermann, C Rogers-Smith, G Leech, B Snodin, J Ahuja, ... Nature communications 12 (1), 5820, 2021 | 224 | 2021 |
Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study NC Grassly, M Pons-Salort, EPK Parker, PJ White, NM Ferguson, ... The Lancet Infectious Diseases 20 (12), 1381-1389, 2020 | 210 | 2020 |
Response to COVID-19 in South Korea and implications for lifting stringent interventions A Dighe, L Cattarino, G Cuomo-Dannenburg, J Skarp, N Imai, S Bhatia, ... BMC medicine 18, 1-12, 2020 | 199 | 2020 |
State-level tracking of COVID-19 in the United States HJT Unwin, S Mishra, VC Bradley, A Gandy, TA Mellan, H Coupland, ... Nature communications 11 (1), 6189, 2020 | 178 | 2020 |
Report 21: Estimating COVID-19 cases and reproduction number in Brazil TA Mellan, HH Hoeltgebaum, S Mishra, C Whittaker, RP Schnekenberg, ... | 141 | 2020 |
SARS-CoV-2 B. 1.617. 2 Delta variant replication, sensitivity to neutralising antibodies and vaccine breakthrough P Mlcochova, S Kemp, MS Dhar, G Papa, B Meng, S Mishra, C Whittaker, ... | 140* | 2021 |
Quantifying online news media coverage of the COVID-19 pandemic: Text mining study and resource K Krawczyk, T Chelkowski, DJ Laydon, S Mishra, D Xifara, B Gibert, ... Journal of medical Internet research 23 (6), e28253, 2021 | 122 | 2021 |
Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England S Mishra, S Mindermann, M Sharma, C Whittaker, TA Mellan, T Wilton, ... EClinicalMedicine 39, 2021 | 120 | 2021 |
Supplementary data–report 34: COVID-19 infection fatality ratio: estimates from seroprevalence N Brazeau, R Verity, S Jenks, H Fu, C Whittaker, P Winskill, I Dorigatti, ... London: Imperial College, 2020 | 111 | 2020 |
SARS-CoV-2 B. 1.617 emergence and sensitivity to vaccine-elicited antibodies I Ferreira, R Datir, G Papa, S Kemp, B Meng, P Rakshit, S Singh, ... BioRxiv, 2021 | 96 | 2021 |
Density functional theory study of rutile VO2 surfaces TA Mellan, R Grau-Crespo The Journal of chemical physics 137 (15), 2012 | 91 | 2012 |